VANGUARD GROUP INC - THRESHOLD PHARMACEUTICAL INC ownership

THRESHOLD PHARMACEUTICAL INC's ticker is THLD and the CUSIP is 885807206. A total of 87 filers reported holding THRESHOLD PHARMACEUTICAL INC in Q2 2014. The put-call ratio across all filers is 0.23 and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of THRESHOLD PHARMACEUTICAL INC
ValueSharesWeighting
Q2 2017$912,000
-32.3%
2,320,126
-1.9%
0.00%
Q1 2017$1,348,000
+49.0%
2,366,223
+15.3%
0.00%
Q4 2016$905,000
-21.9%
2,052,520
+20.1%
0.00%
Q3 2016$1,159,000
-32.4%
1,709,592
-36.6%
0.00%
Q2 2016$1,714,000
+29.8%
2,697,460
-6.1%
0.00%
Q1 2016$1,321,000
+15.0%
2,871,366
+19.9%
0.00%
Q4 2015$1,149,000
-86.5%
2,394,462
+14.8%
0.00%
Q3 2015$8,487,000
+10.2%
2,085,272
+9.3%
0.00%
-100.0%
Q2 2015$7,704,000
+6.8%
1,906,989
+7.3%
0.00%
Q1 2015$7,216,000
+48.2%
1,777,521
+16.1%
0.00%
Q4 2014$4,870,000
-9.4%
1,531,443
+2.9%
0.00%
Q3 2014$5,373,000
-3.4%
1,488,247
+5.9%
0.00%
Q2 2014$5,563,000
-19.8%
1,404,880
-3.6%
0.00%
-100.0%
Q1 2014$6,938,000
+13.4%
1,457,490
+11.2%
0.00%0.0%
Q4 2013$6,119,000
+1.7%
1,310,212
+1.3%
0.00%0.0%
Q3 2013$6,015,000
-4.0%
1,293,573
+8.5%
0.00%0.0%
Q2 2013$6,268,0001,191,7840.00%
Other shareholders
THRESHOLD PHARMACEUTICAL INC shareholders Q2 2014
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 270,500$1,288,0001.11%
Rhenman & Partners Asset Management AB 196,537$936,0000.28%
FORTALEZA ASSET MANAGEMENT INC/ 78,055$372,0000.19%
Baker Brothers Advisors 1,826,358$8,693,0000.11%
Rotella Capital Management, Inc. 14,600$69,0000.08%
FRANKLIN STREET ADVISORS INC /NC 69,700$332,0000.07%
FEDERATED HERMES, INC. 3,036,963$14,456,0000.05%
KINGDON CAPITAL MANAGEMENT, L.L.C. 160,000$760,0000.04%
SMITH ASSET MANAGEMENT GROUP LP 200,118$953,0000.04%
Princeton Alpha Management LP 22,329$106,0000.03%
View complete list of THRESHOLD PHARMACEUTICAL INC shareholders